$XRX
Xerox Holdings Corp

2023 Q1 Form 10-Q Financial Statement

#000177045023000032 Filed on May 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q1
Revenue $1.715B
YoY Change 2.82%
Cost Of Revenue $1.126B
YoY Change -1.05%
Gross Profit $589.0M
YoY Change 11.13%
Gross Profit Margin 34.34%
Selling, General & Admin $407.0M
YoY Change -10.55%
% of Gross Profit 69.1%
Research & Development $64.00M
YoY Change -17.95%
% of Gross Profit 10.87%
Depreciation & Amortization $64.00M
YoY Change -11.11%
% of Gross Profit 10.87%
Operating Expenses $407.0M
YoY Change -10.55%
Operating Profit $182.0M
YoY Change 142.67%
Interest Expense $50.00M
YoY Change -5.66%
% of Operating Profit 27.47%
Other Income/Expense, Net $0.00
YoY Change -100.0%
Pretax Income $85.00M
YoY Change -195.51%
Income Tax $14.00M
% Of Pretax Income 16.47%
Net Earnings $71.00M
YoY Change -226.79%
Net Earnings / Revenue 4.14%
Basic Earnings Per Share $0.43
Diluted Earnings Per Share $0.43
COMMON SHARES
Basic Shares Outstanding 156.4M shares
Diluted Shares Outstanding 156.7M shares

Balance Sheet

Concept 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $591.0M
YoY Change -64.84%
Cash & Equivalents $591.0M
Short-Term Investments
Other Short-Term Assets $252.0M
YoY Change 7.69%
Inventory $863.0M
Prepaid Expenses
Receivables $818.0M
Other Receivables $1.022B
Total Short-Term Assets $3.640B
YoY Change -20.28%
LONG-TERM ASSETS
Property, Plant & Equipment $250.0M
YoY Change -1.57%
Goodwill $2.850B
YoY Change -13.64%
Intangibles $202.0M
YoY Change -15.83%
Long-Term Investments
YoY Change
Other Assets $1.331B
YoY Change -31.78%
Total Long-Term Assets $7.406B
YoY Change -13.03%
TOTAL ASSETS
Total Short-Term Assets $3.640B
Total Long-Term Assets $7.406B
Total Assets $11.05B
YoY Change -15.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.301B
YoY Change 9.97%
Accrued Expenses $304.0M
YoY Change -9.79%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $553.0M
YoY Change -61.86%
Total Short-Term Liabilities $2.879B
YoY Change -23.61%
LONG-TERM LIABILITIES
Long-Term Debt $2.726B
YoY Change -3.37%
Other Long-Term Liabilities $400.0M
YoY Change -15.43%
Total Long-Term Liabilities $400.0M
YoY Change -15.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.879B
Total Long-Term Liabilities $400.0M
Total Liabilities $7.355B
YoY Change -15.16%
SHAREHOLDERS EQUITY
Retained Earnings $5.162B
YoY Change -6.69%
Common Stock $1.751B
YoY Change 2.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.459B
YoY Change
Total Liabilities & Shareholders Equity $11.05B
YoY Change -15.56%

Cashflow Statement

Concept 2023 Q1
OPERATING ACTIVITIES
Net Income $71.00M
YoY Change -226.79%
Depreciation, Depletion And Amortization $64.00M
YoY Change -11.11%
Cash From Operating Activities $78.00M
YoY Change 18.18%
INVESTING ACTIVITIES
Capital Expenditures $6.000M
YoY Change -50.0%
Acquisitions $7.000M
YoY Change -87.04%
Other Investing Activities $3.000M
YoY Change -40.0%
Cash From Investing Activities -$17.00M
YoY Change -77.33%
FINANCING ACTIVITIES
Cash Dividend Paid $45.00M
YoY Change -2.17%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $452.0M
YoY Change -30.03%
Cash From Financing Activities -$505.0M
YoY Change 238.93%
NET CHANGE
Cash From Operating Activities $78.00M
Cash From Investing Activities -$17.00M
Cash From Financing Activities -$505.0M
Net Change In Cash -$442.0M
YoY Change 198.65%
FREE CASH FLOW
Cash From Operating Activities $78.00M
Capital Expenditures $6.000M
Free Cash Flow $72.00M
YoY Change 33.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001770450
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Sales Type Lease Income Comprehensive Income Extensible List
SalesTypeLeaseIncomeComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerExcludingAssessedTax
CY2023Q1 us-gaap Operating Lease Income Comprehensive Income Extensible List
OperatingLeaseIncomeComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerExcludingAssessedTax
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.xerox.com/20230331#AccruedAndOtherLiabilitiesCurrent
CY2023Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.xerox.com/20230331#AccruedAndOtherLiabilitiesCurrent
CY2023Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1 us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://www.xerox.com/20230331#OtherExpenseIncomeNet
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P4Y
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
XEROX HOLDINGS CORPORATION
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2023Q1 dei Entity File Number
EntityFileNumber
001-39013
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-3933743
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
P.O. Box 4505
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
201 Merritt 7
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Norwalk
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06851-1056
CY2023Q1 dei City Area Code
CityAreaCode
(203)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
849-5216
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $1 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
XRX
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
156958464 shares
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1715000000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1668000000 usd
CY2023Q1 us-gaap Financing Interest Expense
FinancingInterestExpense
36000000 usd
CY2022Q1 us-gaap Financing Interest Expense
FinancingInterestExpense
24000000 usd
CY2023Q1 xrx Research Development And Engineering Expenses
ResearchDevelopmentAndEngineeringExpenses
64000000 usd
CY2022Q1 xrx Research Development And Engineering Expenses
ResearchDevelopmentAndEngineeringExpenses
78000000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
407000000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
455000000 usd
CY2023Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
2000000 usd
CY2022Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
18000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11000000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11000000 usd
CY2023Q1 xrx Other Expense Income Net
OtherExpenseIncomeNet
20000000 usd
CY2022Q1 xrx Other Expense Income Net
OtherExpenseIncomeNet
57000000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
1630000000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
1757000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
85000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-89000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-31000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
71000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-57000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
0 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-1000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
71000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-56000000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2023Q1 us-gaap Profit Loss
ProfitLoss
71000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-57000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
0 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-1000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
71000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-56000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
92000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-72000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
4000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-11000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
14000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-39000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
82000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-44000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-1000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
83000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-44000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
153000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-101000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
154000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-100000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
591000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1045000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
53000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
52000000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
818000000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
857000000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Current
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent
4000000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Current
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent
4000000 usd
CY2023Q1 xrx Billed Portion Of Finance Receivables Net
BilledPortionOfFinanceReceivablesNet
94000000 usd
CY2022Q4 xrx Billed Portion Of Finance Receivables Net
BilledPortionOfFinanceReceivablesNet
93000000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent
1022000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent
1061000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
863000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
797000000 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
252000000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
254000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
3640000000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4107000000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Noncurrent
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestNoncurrent
97000000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Noncurrent
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestNoncurrent
113000000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent
1864000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent
1948000000 usd
CY2023Q1 xrx Assets Leased To Others
AssetsLeasedToOthers
250000000 usd
CY2022Q4 xrx Assets Leased To Others
AssetsLeasedToOthers
235000000 usd
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
311000000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
320000000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
202000000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
208000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
2850000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
2820000000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
598000000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
582000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1331000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1323000000 usd
CY2023Q1 us-gaap Assets
Assets
11046000000 usd
CY2022Q4 us-gaap Assets
Assets
11543000000 usd
CY2023Q1 us-gaap Debt Current
DebtCurrent
553000000 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
860000000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1301000000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1331000000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
243000000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
258000000 usd
CY2023Q1 xrx Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
782000000 usd
CY2022Q4 xrx Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
881000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2879000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3330000000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
2726000000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
2866000000 usd
CY2023Q1 xrx Pension And Other Benefit Liabilities
PensionAndOtherBenefitLiabilities
1168000000 usd
CY2022Q4 xrx Pension And Other Benefit Liabilities
PensionAndOtherBenefitLiabilities
1175000000 usd
CY2023Q1 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
182000000 usd
CY2022Q4 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
184000000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
400000000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
411000000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
7355000000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
7966000000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
10000000 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
10000000 usd
CY2023Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
214000000 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
214000000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
157000000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
156000000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1594000000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1588000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5162000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5136000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3454000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3537000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3459000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3343000000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
8000000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
10000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3467000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3353000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11046000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11543000000 usd
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
156958000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
156958000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155781000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
155781000 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
71000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-57000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
64000000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
72000000 usd
CY2023Q1 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
0 usd
CY2022Q1 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
19000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
14000000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
15000000 usd
CY2023Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
1000000 usd
CY2022Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
20000000 usd
CY2023Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
6000000 usd
CY2022Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
7000000 usd
CY2023Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-1000000 usd
CY2022Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-7000000 usd
CY2023Q1 us-gaap Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
17000000 usd
CY2022Q1 us-gaap Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
38000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-39000000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13000000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
64000000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31000000 usd
CY2023Q1 xrx Increase Decrease In Equipment On Operating Lease
IncreaseDecreaseInEquipmentOnOperatingLease
40000000 usd
CY2022Q1 xrx Increase Decrease In Equipment On Operating Lease
IncreaseDecreaseInEquipmentOnOperatingLease
36000000 usd
CY2023Q1 us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
-160000000 usd
CY2022Q1 us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
-41000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3000000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-41000000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
111000000 usd
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-16000000 usd
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
22000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-128000000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-43000000 usd
CY2023Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
18000000 usd
CY2022Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-39000000 usd
CY2023Q1 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-13000000 usd
CY2022Q1 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-7000000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
8000000 usd
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
5000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
78000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
66000000 usd
CY2023Q1 xrx Payments To Acquire Property Plant And Equipment And Software
PaymentsToAcquirePropertyPlantAndEquipmentAndSoftware
8000000 usd
CY2022Q1 xrx Payments To Acquire Property Plant And Equipment And Software
PaymentsToAcquirePropertyPlantAndEquipmentAndSoftware
16000000 usd
CY2023Q1 xrx Proceedsfromsalesofbusinessesandassets
Proceedsfromsalesofbusinessesandassets
1000000 usd
CY2022Q1 xrx Proceedsfromsalesofbusinessesandassets
Proceedsfromsalesofbusinessesandassets
0 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
7000000 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
54000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
3000000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
5000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-75000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
668000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
452000000 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
646000000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
45000000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
46000000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
113000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-8000000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-12000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-505000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-149000000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2000000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-442000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-148000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1139000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1909000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
697000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1761000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
2850000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
2820000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1715000000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1668000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1715000000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1668000000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
132000000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
131000000 usd
CY2023Q1 xrx Contract With Customer Liability Amortization Period
ContractWithCustomerLiabilityAmortizationPeriod
P30M
CY2023Q1 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P4Y
CY2023Q1 xrx Incremental Direct Costs Of Obtaining A Contract
IncrementalDirectCostsOfObtainingAContract
16000000 usd
CY2022Q1 xrx Incremental Direct Costs Of Obtaining A Contract
IncrementalDirectCostsOfObtainingAContract
13000000 usd
CY2023Q1 xrx Capitalized Contract Costs Amortization Reported In Decrease Increase In Other Current And Long Term Assets
CapitalizedContractCostsAmortizationReportedInDecreaseIncreaseInOtherCurrentAndLongTermAssets
16000000 usd
CY2022Q1 xrx Capitalized Contract Costs Amortization Reported In Decrease Increase In Other Current And Long Term Assets
CapitalizedContractCostsAmortizationReportedInDecreaseIncreaseInOtherCurrentAndLongTermAssets
18000000 usd
CY2023Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
125000000 usd
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
125000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1715000000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1668000000 usd
CY2023Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
2000000 usd
CY2022Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
18000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11000000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11000000 usd
CY2023Q1 xrx Other Expense Income Net
OtherExpenseIncomeNet
20000000 usd
CY2022Q1 xrx Other Expense Income Net
OtherExpenseIncomeNet
57000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
85000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-89000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11000000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
64000000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
72000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
50000000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
53000000 usd
CY2023Q1 xrx Interest Income
InterestIncome
57000000 usd
CY2022Q1 xrx Interest Income
InterestIncome
54000000 usd
CY2023Q1 us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
230000000 usd
CY2022Q1 us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
135000000 usd
CY2023Q1 us-gaap Sales Type Lease Interest Income Lease Receivable
SalesTypeLeaseInterestIncomeLeaseReceivable
52000000 usd
CY2022Q1 us-gaap Sales Type Lease Interest Income Lease Receivable
SalesTypeLeaseInterestIncomeLeaseReceivable
53000000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
40000000 usd
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
48000000 usd
CY2023Q1 us-gaap Variable Lease Income
VariableLeaseIncome
17000000 usd
CY2022Q1 us-gaap Variable Lease Income
VariableLeaseIncome
15000000 usd
CY2023Q1 us-gaap Lease Income
LeaseIncome
339000000 usd
CY2022Q1 us-gaap Lease Income
LeaseIncome
251000000 usd
CY2023Q1 us-gaap Sales Type Lease Selling Profit Loss
SalesTypeLeaseSellingProfitLoss
80000000 usd
CY2022Q1 us-gaap Sales Type Lease Selling Profit Loss
SalesTypeLeaseSellingProfitLoss
44000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
591000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1045000000 usd
CY2023Q1 xrx Tax And Labor Litigation Deposits In Brazil
TaxAndLaborLitigationDepositsInBrazil
40000000 usd
CY2022Q4 xrx Tax And Labor Litigation Deposits In Brazil
TaxAndLaborLitigationDepositsInBrazil
39000000 usd
CY2023Q1 us-gaap Receivables Held For Sale Amount
ReceivablesHeldForSaleAmount
65000000 usd
CY2022Q4 us-gaap Receivables Held For Sale Amount
ReceivablesHeldForSaleAmount
54000000 usd
CY2023Q1 xrx Other Restricted Cash
OtherRestrictedCash
1000000 usd
CY2022Q4 xrx Other Restricted Cash
OtherRestrictedCash
1000000 usd
CY2023Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
106000000 usd
CY2022Q4 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
94000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
697000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1139000000 usd
CY2023Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
106000000 usd
CY2022Q4 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
94000000 usd
CY2023Q1 xrx Receivable Credit Loss Expense Reversal
ReceivableCreditLossExpenseReversal
-5000000 usd
CY2022Q1 xrx Receivable Credit Loss Expense Reversal
ReceivableCreditLossExpenseReversal
14000000 usd
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
5000000 usd
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
5000000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
16000000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
18000000 usd
CY2023Q1 xrx Depreciation Expense Assets Leased To Others
DepreciationExpenseAssetsLeasedToOthers
27000000 usd
CY2022Q1 xrx Depreciation Expense Assets Leased To Others
DepreciationExpenseAssetsLeasedToOthers
32000000 usd
CY2023Q1 xrx Amortization Of Internal Use Software
AmortizationOfInternalUseSoftware
10000000 usd
CY2022Q1 xrx Amortization Of Internal Use Software
AmortizationOfInternalUseSoftware
11000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11000000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11000000 usd
CY2023Q1 xrx Amortization Of Patents
AmortizationOfPatents
2000000 usd
CY2022Q1 xrx Amortization Of Patents
AmortizationOfPatents
3000000 usd
CY2023Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
16000000 usd
CY2022Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
19000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6000000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12000000 usd
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2000000 usd
CY2022Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
4000000 usd
CY2023Q1 xrx Investments In Noncontrolling Interests
InvestmentsInNoncontrollingInterests
3000000 usd
CY2022Q1 xrx Investments In Noncontrolling Interests
InvestmentsInNoncontrollingInterests
5000000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
41000000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
42000000 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
4000000 usd
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
4000000 usd
CY2023Q1 xrx Dividends Distributions And Other Payments To Noncontrolling Interests
DividendsDistributionsAndOtherPaymentsToNoncontrollingInterests
1000000 usd
CY2022Q1 xrx Dividends Distributions And Other Payments To Noncontrolling Interests
DividendsDistributionsAndOtherPaymentsToNoncontrollingInterests
1000000 usd
CY2023Q1 xrx Payments For Repurchase Of Common Stock Share Based Compensation
PaymentsForRepurchaseOfCommonStockShareBasedCompensation
6000000 usd
CY2022Q1 xrx Payments For Repurchase Of Common Stock Share Based Compensation
PaymentsForRepurchaseOfCommonStockShareBasedCompensation
10000000 usd
CY2022Q4 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
374000000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
3081000000 usd
CY2023Q1 xrx Account Receivable Sale Number Of Facilities
AccountReceivableSaleNumberOfFacilities
1 facility
CY2023Q1 xrx Remaining Account Receivable Sold And Derecognized
RemainingAccountReceivableSoldAndDerecognized
73000000 usd
CY2022Q4 xrx Remaining Account Receivable Sold And Derecognized
RemainingAccountReceivableSoldAndDerecognized
159000000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Noncurrent
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossNoncurrent
3438000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Noncurrent
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossNoncurrent
3593000000 usd
CY2023Q1 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
357000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
3219000000 usd
CY2023Q1 xrx Financing Receivable Residual Values
FinancingReceivableResidualValues
0 usd
CY2022Q4 xrx Financing Receivable Residual Values
FinancingReceivableResidualValues
0 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
101000000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
117000000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
2980000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
3102000000 usd
CY2023Q1 us-gaap Billed Contract Receivables
BilledContractReceivables
94000000 usd
CY2022Q4 us-gaap Billed Contract Receivables
BilledContractReceivables
93000000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent
1022000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent
1061000000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent
1864000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent
1948000000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
117000000 usd
CY2023Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-12000000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
7000000 usd
CY2023Q1 xrx Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recoveries And Other
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecoveriesAndOther
3000000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
101000000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
118000000 usd
CY2022Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
6000000 usd
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
4000000 usd
CY2022Q1 xrx Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recoveries And Other
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecoveriesAndOther
0 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
120000000 usd
CY2023Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3081000000 usd
CY2022Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3125000000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
101000000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
120000000 usd
CY2023Q1 xrx Loss Rates Of Customers With Investment Grade Credit Quality
LossRatesOfCustomersWithInvestmentGradeCreditQuality
0.01
CY2023Q1 xrx Loss Rates Of Customers With Non Investment Grade Credit Quality Low Range
LossRatesOfCustomersWithNonInvestmentGradeCreditQualityLowRange
0.02
CY2023Q1 xrx Loss Rates Of Customers With Non Investment Grade Credit Quality High Range
LossRatesOfCustomersWithNonInvestmentGradeCreditQualityHighRange
0.05
CY2023Q1 xrx Loss Rate Of Customers With Substandard Doubtful Credit Quality Low
LossRateOfCustomersWithSubstandardDoubtfulCreditQualityLow
0.07
CY2023Q1 xrx Loss Rate Of Customers With Substandard Doubtful Credit Quality High
LossRateOfCustomersWithSubstandardDoubtfulCreditQualityHigh
0.10
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
441000000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
1063000000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
774000000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
455000000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
266000000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
82000000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
3081000000 usd
CY2023Q1 xrx Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff
0 usd
CY2023Q1 xrx Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff
1000000 usd
CY2023Q1 xrx Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff
1000000 usd
CY2023Q1 xrx Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff
0 usd
CY2023Q1 xrx Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff
1000000 usd
CY2023Q1 xrx Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteoff
4000000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
7000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
1329000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
889000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
537000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
334000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
114000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
16000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
3219000000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
3081000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
3219000000 usd
CY2023Q1 xrx Financing Receivable Automatic Extension Period
FinancingReceivableAutomaticExtensionPeriod
P1Y
CY2023Q1 us-gaap Financing Receivable Sale
FinancingReceivableSale
600000000 usd
CY2023Q1 xrx Financing Receivable Sale Amount Derecognized Remaining Uncollected Amount
FinancingReceivableSaleAmountDerecognizedRemainingUncollectedAmount
311000000 usd
CY2022Q4 xrx Financing Receivable Sale Amount Derecognized Remaining Uncollected Amount
FinancingReceivableSaleAmountDerecognizedRemainingUncollectedAmount
60000000 usd
CY2023Q1 us-gaap Proceeds From Sale And Collection Of Finance Receivables
ProceedsFromSaleAndCollectionOfFinanceReceivables
261000000 usd
CY2022 us-gaap Proceeds From Sale And Collection Of Finance Receivables
ProceedsFromSaleAndCollectionOfFinanceReceivables
61000000 usd
CY2023Q1 xrx Gain Loss On Sale Commissions
GainLossOnSaleCommissions
2000000 usd
CY2022 xrx Gain Loss On Sale Commissions
GainLossOnSaleCommissions
2000000 usd
CY2023Q1 xrx Finance Receivable Sale Servicing Revenue
FinanceReceivableSaleServicingRevenue
1000000 usd
CY2022 xrx Finance Receivable Sale Servicing Revenue
FinanceReceivableSaleServicingRevenue
0 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
699000000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
640000000 usd
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
49000000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
45000000 usd
CY2023Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
115000000 usd
CY2022Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
112000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
863000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
797000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1161000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1163000000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
911000000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
928000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
250000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
235000000 usd
CY2023Q1 xrx Operating Leases Charges In Excess Of Minimum Contracted Amounts
OperatingLeasesChargesInExcessOfMinimumContractedAmounts
17000000 usd
CY2022Q1 xrx Operating Leases Charges In Excess Of Minimum Contracted Amounts
OperatingLeasesChargesInExcessOfMinimumContractedAmounts
15000000 usd
CY2023Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12Y
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
61000000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
68000000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
23000000 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
25000000 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
4000000 usd
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
4000000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
13000000 usd
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
12000000 usd
CY2023Q1 us-gaap Sublease Income
SubleaseIncome
1000000 usd
CY2022Q1 us-gaap Sublease Income
SubleaseIncome
2000000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
39000000 usd
CY2022Q1 us-gaap Lease Cost
LeaseCost
39000000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
201000000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
215000000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
153000000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
161000000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
214000000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
229000000 usd
CY2023Q1 xrx Restructuring Net Current Period Charges
RestructuringNetCurrentPeriodCharges
1000000 usd
CY2023Q1 us-gaap Restructuring And Related Cost Expected Number Of Positions Eliminated
RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated
100 employee
CY2023Q1 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
4000000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
43000000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
5000000 usd
CY2023Q1 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
4000000 usd
CY2023Q1 xrx Restructuring Net Current Period Charges
RestructuringNetCurrentPeriodCharges
1000000 usd
CY2023Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
6000000 usd
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
38000000 usd
CY2023Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
6000000 usd
CY2022Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
7000000 usd
CY2023Q1 us-gaap Restructuring Reserve Translation And Other Adjustment
RestructuringReserveTranslationAndOtherAdjustment
0 usd
CY2022Q1 us-gaap Restructuring Reserve Translation And Other Adjustment
RestructuringReserveTranslationAndOtherAdjustment
0 usd
CY2023Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
6000000 usd
CY2022Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
7000000 usd
CY2023Q1 xrx Related Restructuring Costs
RelatedRestructuringCosts
1000000 usd
CY2022Q1 xrx Related Restructuring Costs
RelatedRestructuringCosts
-2000000 usd
CY2023Q1 xrx Restructuring Related Reserve
RestructuringRelatedReserve
12000000 usd
CY2022Q4 xrx Restructuring Related Reserve
RestructuringRelatedReserve
12000000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
50000000 usd
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
53000000 usd
CY2023Q1 xrx Interest Income
InterestIncome
57000000 usd
CY2022Q1 xrx Interest Income
InterestIncome
54000000 usd
CY2023Q1 us-gaap Derivative Number Of Instruments Held
DerivativeNumberOfInstrumentsHeld
4 derivative
CY2023Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
893000000 usd
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
6000000 usd
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
4000000 usd
CY2023Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
1301000000 usd
CY2022Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
1541000000 usd
CY2023Q1 xrx Average Maturity Of Foreign Exchange Hedging Contracts Within Three Months
AverageMaturityOfForeignExchangeHedgingContractsWithinThreeMonths
0.87
CY2023Q1 xrx Average Maturity Of Foreign Exchange Hedging Contracts Within Three And Six Months
AverageMaturityOfForeignExchangeHedgingContractsWithinThreeAndSixMonths
0.07
CY2023Q1 xrx Average Maturity Of Foreign Exchange Hedging Contracts Within Six And Twelve Months
AverageMaturityOfForeignExchangeHedgingContractsWithinSixAndTwelveMonths
0.06
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
14000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
26000000 usd
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
8000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
11000000 usd
CY2023Q1 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
6000000 usd
CY2022Q4 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
15000000 usd
CY2023Q1 us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
0 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4443000000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-11000000 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
CY2023Q1 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
17000000 usd
CY2022Q1 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
38000000 usd
CY2022Q4 us-gaap Defined Benefit Plan Expected Future Employer Contributions Current Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear
105000000 usd
CY2022 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
124000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3353000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
153000000 usd
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
41000000 usd
CY2023Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
4000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7000000 usd
CY2023Q1 xrx Distributions And Purchases Noncontrolling Interests
DistributionsAndPurchasesNoncontrollingInterests
1000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3467000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-101000000 usd
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
39000000 usd
CY2022Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
4000000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4000000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
113000000 usd
CY2022Q1 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 usd
CY2022Q1 xrx Distributions And Purchases Noncontrolling Interests
DistributionsAndPurchasesNoncontrollingInterests
1000000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4189000000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2022Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
20.00
CY2023Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
20.00
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
84000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
82000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-35000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-44000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest
-1000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-1000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
71000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-56000000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
4000000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
4000000 usd
CY2023Q1 xrx Adjusted Net Income Availableto Common Shareholders Common
AdjustedNetIncomeAvailabletoCommonShareholdersCommon
67000000 usd
CY2022Q1 xrx Adjusted Net Income Availableto Common Shareholders Common
AdjustedNetIncomeAvailabletoCommonShareholdersCommon
-60000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
156661000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
156362000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
71000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-56000000 usd
CY2023Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
4000000 usd
CY2022Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
4000000 usd
CY2023Q1 xrx Adjusted Net Income Loss Availableto Common Shareholders Diluted
AdjustedNetIncomeLossAvailabletoCommonShareholdersDiluted
67000000 usd
CY2022Q1 xrx Adjusted Net Income Loss Availableto Common Shareholders Diluted
AdjustedNetIncomeLossAvailabletoCommonShareholdersDiluted
-60000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
156661000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
156362000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
157746000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
156362000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13705000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13824000 shares
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25

Files In Submission

Name View Source Status
0001770450-23-000032-index-headers.html Edgar Link pending
0001770450-23-000032-index.html Edgar Link pending
0001770450-23-000032.txt Edgar Link pending
0001770450-23-000032-xbrl.zip Edgar Link pending
ex31a1-xeroxholdingsx33123.htm Edgar Link pending
ex31a2-xeroxcorpx33123ceoc.htm Edgar Link pending
ex31b1-xeroxholdingsx33123.htm Edgar Link pending
ex31b2-xeroxcorpx33123cfoc.htm Edgar Link pending
ex32a-xeroxholdingsx33123s.htm Edgar Link pending
ex32b-xeroxcorpx33123soxce.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xrx-20230331.htm Edgar Link pending
xrx-20230331.xsd Edgar Link pending
xrx-20230331_g1.jpg Edgar Link pending
xrx-20230331_def.xml Edgar Link unprocessable
xrx-20230331_cal.xml Edgar Link unprocessable
xrx-20230331_lab.xml Edgar Link unprocessable
xrx-20230331_pre.xml Edgar Link unprocessable
xrx-20230331_htm.xml Edgar Link completed